Generics, Branded Generics, Biosimilars and the Changing NHS
Friday 30th January 2026 13:00 - 14:00 (GMT)
Balancing Budget Pressures and Patient Need: The role of Generics and Biosimilars in the changing NHS landscape
Masterclass Details:
Generics, Branded Generics and Biosimilars remain essential to the NHS, driving both access and affordability across almost every therapy area. As we begin 2026, new challenges and expectations are shaping how these medicines are positioned, commissioned and delivered.
In this 60-minute masterclass, a panel of experienced leaders from across the UK market will provide a comprehensive update on the latest policy shifts, pricing pressures and procurement changes that could influence your strategy.
Whether you lead a portfolio, manage accounts or shape access strategy, this is your opportunity to hear how key players are responding to the evolving NHS environment and how the Life Sciences industry can continue to add value amid increasing scrutiny, tighter margins and greater demands for transparency.
Join live to hear direct insight and pose your questions to our experts from across the Generics, Branded Generics and Biosimilars industry.
Key Learning Objectives:
- Identify current NHS priorities and their implications for Generics, Branded Generics and Biosimilars
- Explore how the value proposition of these medicines is evolving in 2026
- Understand recent developments in procurement, pricing and market competition
- Learn how industry leaders are adapting to access challenges and finding new opportunities
- Discover how to differentiate your strategy in 2026
LSAA reserves the right to restrict access to this webinar to LSAA members.
-
Date and time
30th Jan 2026 13:00 – 14:00 (GMT)
